New injection shows promise against tough cancers
Disease control
Recruiting now
This early-stage study tests a new drug called STX-001, given as an injection directly into tumors, either alone or with another drug (pembrolizumab). The goal is to see if it is safe and can shrink or control advanced solid tumors, including melanoma. About 108 adults with tumor…
Phase: PHASE1, PHASE2 • Sponsor: Strand Therapeutics Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC